APO RESEARCH · REPORT
Induced Pluripotent Stem Cells (iPSCs)
Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.
Product & engineering
Understand the product.
Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.
Selected research
Industry Growth & Trends
Global Induced Pluripotent Stem Cells (iPSCs) Industry Growth and Trends Forecast to 2032
Market perspective
Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.
According to APO Research, the global Induced Pluripotent Stem Cells (iPSCs) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Induced Pluripotent Stem Cells (iPSCs) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Induced Pluripotent Stem Cells (iPSCs) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Induced Pluripotent Stem Cells (iPSCs) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Induced Pluripotent Stem Cells (iPSCs).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Induced Pluripotent Stem Cells (iPSCs) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Induced Pluripotent Stem Cells (iPSCs) Market by Company
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL
Induced Pluripotent Stem Cells (iPSCs) Segment by Type
Human iPSCs
Mouse iPSCs
Induced Pluripotent Stem Cells (iPSCs) Segment by Application
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
Induced Pluripotent Stem Cells (iPSCs) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Induced Pluripotent Stem Cells (iPSCs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Induced Pluripotent Stem Cells (iPSCs) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Induced Pluripotent Stem Cells (iPSCs).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Induced Pluripotent Stem Cells (iPSCs) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Human iPSCs
- Mouse iPSCs
Applications
- Academic Research
- Drug Development and Discovery
- Toxicity Screening
- Regenerative Medicine
- Others
Companies covered
- Fujifilm Holding Corporation (CDI)
- Ncardia
- Sumitomo Dainippon Pharma
- Astellas Pharma Inc
- Fate Therapeutics, Inc
- Pluricell Biotech
- Cell Inspire Biotechnology
- ReproCELL
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2021-2032)
- 1.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2021-2026)
- 1.4.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2027-2032)
- 1.5 Key Regions Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032)
- 1.5.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2021-2032)
- 1.5.4 South America Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2021-2032)
2 Induced Pluripotent Stem Cells (iPSCs) Market by Type
- 2.1 Type Introduction
- 2.1.1 Human iPSCs
- 2.1.2 Mouse iPSCs
- 2.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
- 2.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Overview by Type (2021-2032)
- 2.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecasted by Type (2027-2032)
- 2.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions
- 2.3.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Type (2021-2026)
3 Induced Pluripotent Stem Cells (iPSCs) Market by Application
- 3.1 Type Introduction
- 3.1.1 Academic Research
- 3.1.2 Drug Development and Discovery
- 3.1.3 Toxicity Screening
- 3.1.4 Regenerative Medicine
- 3.1.5 Others
- 3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
- 3.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Overview by Application (2021-2032)
- 3.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecasted by Application (2027-2032)
- 3.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions
- 3.3.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Induced Pluripotent Stem Cells (iPSCs) Industry Trends
- 4.2 Induced Pluripotent Stem Cells (iPSCs) Industry Drivers
- 4.3 Induced Pluripotent Stem Cells (iPSCs) Industry Opportunities and Challenges
- 4.4 Induced Pluripotent Stem Cells (iPSCs) Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Induced Pluripotent Stem Cells (iPSCs) Revenue (2021-2026)
- 5.2 Global Induced Pluripotent Stem Cells (iPSCs) Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Induced Pluripotent Stem Cells (iPSCs) Key Company Headquarters & Area Served
- 5.4 Global Induced Pluripotent Stem Cells (iPSCs) Company, Product Type & Application
- 5.5 Global Induced Pluripotent Stem Cells (iPSCs) Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Induced Pluripotent Stem Cells (iPSCs) Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Induced Pluripotent Stem Cells (iPSCs) Players Market Share by Revenue in 2025
- 5.6.3 2025 Induced Pluripotent Stem Cells (iPSCs) Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Fujifilm Holding Corporation (CDI)
- 6.1.1 Fujifilm Holding Corporation (CDI) Company Information
- 6.1.2 Fujifilm Holding Corporation (CDI) Business Overview
- 6.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
- 6.1.5 Fujifilm Holding Corporation (CDI) Recent Developments
- 6.2 Ncardia
- 6.2.1 Ncardia Company Information
- 6.2.2 Ncardia Business Overview
- 6.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
- 6.2.5 Ncardia Recent Developments
- 6.3 Sumitomo Dainippon Pharma
- 6.3.1 Sumitomo Dainippon Pharma Company Information
- 6.3.2 Sumitomo Dainippon Pharma Business Overview
- 6.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
- 6.3.5 Sumitomo Dainippon Pharma Recent Developments
- 6.4 Astellas Pharma Inc
- 6.4.1 Astellas Pharma Inc Company Information
- 6.4.2 Astellas Pharma Inc Business Overview
- 6.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
- 6.4.5 Astellas Pharma Inc Recent Developments
- 6.5 Fate Therapeutics, Inc
- 6.5.1 Fate Therapeutics, Inc Company Information
- 6.5.2 Fate Therapeutics, Inc Business Overview
- 6.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
- 6.5.5 Fate Therapeutics, Inc Recent Developments
- 6.6 Pluricell Biotech
- 6.6.1 Pluricell Biotech Company Information
- 6.6.2 Pluricell Biotech Business Overview
- 6.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
- 6.6.5 Pluricell Biotech Recent Developments
- 6.7 Cell Inspire Biotechnology
- 6.7.1 Cell Inspire Biotechnology Company Information
- 6.7.2 Cell Inspire Biotechnology Business Overview
- 6.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
- 6.7.5 Cell Inspire Biotechnology Recent Developments
- 6.8 ReproCELL
- 6.8.1 ReproCELL Company Information
- 6.8.2 ReproCELL Business Overview
- 6.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
- 6.8.5 ReproCELL Recent Developments
7 North America
- 7.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026)
- 7.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026)
- 8.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026)
- 10.3 South America Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst